Literature DB >> 28511427

Role of Omega-3 Fatty Acids on Lipid Profile in Diabetic Dyslipidaemia: Single Blind, Randomised Clinical Trial.

Shaylika Chauhan1, Hanish Kodali2, Jawad Noor3, Karuna Ramteke4, Vidisha Gawai5.   

Abstract

INTRODUCTION: Diabetic dyslipidaemia is characterised by hypertriglyceridaemia, low High Density Lipoprotein (HDL), postprandial lipimea, small and dense LDL particles is considered to be a major predisposing factor for various macrovascular complications. Omega-3 fatty acids are fish oil derivative introduced in the market for dyslipidaemia associated with increased triglyceride level. AIM: To study the effect of omega-3 fatty acids on lipid profile in Type II diabetes patients.
MATERIALS AND METHODS: This study was prospective, single blind, randomized comparative trial. Hundred patients were randomized into three groups. Group I received metformin 500 mg twice daily and placebo, Group II received metformin 500 mg twice daily and omega-3 fatty acids (1 gram) once daily and the Group III received metformin 500 mg twice daily and omega-3 fatty acids (1 gram) twice daily. ANOVA test was applied for analysis.
RESULTS: Group II was effective in reducing the triglyceride level from 144.59±14.18 mg/dl to 101±13.31 mg/dl which was significant as compared to Group I from 147.67±18.57 mg/dl to 145.8±19.86 mg/dl respectively. Group III containing 1 g of omega-3 fatty acids twice daily showed decrease from 144.83±22.17 mg/dl to 86±17.46 mg/dl and was more effective in reducing triglyceride levels than Group II containing 1 gram of omega-3 fatty acids once daily.
CONCLUSION: Omega-3 fatty acids can be given in conjunction with metformin to reduce triglyceride levels in diabetic dyslipidaemia without any adverse drug reactions or any drug interaction. Omega-3 fatty acids were effective in reducing the triglyceride level significantly as compared to placebo. Two grams of omega-3 fatty acids were more effective than 1 gram of omega-3 fatty acids in reducing triglyceride levels.

Entities:  

Keywords:  Hypertriglyceridaemia; Postprandial lipimea; Triglyceride

Year:  2017        PMID: 28511427      PMCID: PMC5427353          DOI: 10.7860/JCDR/2017/20628.9449

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  20 in total

1.  Fish oil and glycemic control in diabetes. A meta-analysis.

Authors:  C E Friedberg; M J Janssen; R J Heine; D E Grobbee
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

Review 2.  Classification and diagnosis of diabetes mellitus.

Authors:  S Genuth
Journal:  Med Clin North Am       Date:  1982-11       Impact factor: 5.456

3.  Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.

Authors:  M Borkman; D J Chisholm; S M Furler; L H Storlien; E W Kraegen; L A Simons; C N Chesterman
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

4.  Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.

Authors:  K E Friday; M T Childs; C H Tsunehara; W Y Fujimoto; E L Bierman; J W Ensinck
Journal:  Diabetes Care       Date:  1989-04       Impact factor: 19.112

Review 5.  Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

6.  Effect of n-3 fatty acid supplementation on blood glucose, lipid profile and cytokines in humans: A pilot study.

Authors:  B Raghu; P Venkatesan
Journal:  Indian J Clin Biochem       Date:  2008-03-06

Review 7.  Lipoprotein disorders in diabetes mellitus.

Authors:  W V Brown
Journal:  Med Clin North Am       Date:  1994-01       Impact factor: 5.456

Review 8.  Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.

Authors:  Harold E Bays; Ann P Tighe; Richard Sadovsky; Michael H Davidson
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-03

Review 9.  Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus.

Authors:  Nadeem Tajuddin; Ali Shaikh; Amir Hassan
Journal:  Diabetes Metab Syndr Obes       Date:  2016-04-19       Impact factor: 3.168

Review 10.  Insulin-Sensitizing Effects of Omega-3 Fatty Acids: Lost in Translation?

Authors:  Antigoni Z Lalia; Ian R Lanza
Journal:  Nutrients       Date:  2016-06-01       Impact factor: 5.717

View more
  3 in total

1.  Effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes mellitus: A randomized clinical trial.

Authors:  Masoud Khorshidi; Aliakbar Sayyari; Naheed Aryaeian; Beheshteh Olang; Mohammadreza Alaei; Mitra Khalili; Amirhossein Hosseini; Masoud Salehi
Journal:  Front Nutr       Date:  2022-07-22

Review 2.  Nutritional Values of Teff (Eragrostis tef) in Diabetic Patients: Narrative Review.

Authors:  Mezgebu Legesse Habte; Etsegenet Assefa Beyene; Teka Obsa Feyisa; Fitalew Tadele Admasu; Anmut Tilahun; Getahun Chala Diribsa
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-22       Impact factor: 3.249

3.  Omega-3 polyunsaturated fatty acid supplementation for improving peripheral nerve health: protocol for a systematic review.

Authors:  Alexis Ceecee Zhang; Richard J MacIsaac; Leslie Roberts; Jordan Kamel; Jennifer P Craig; Lucy Busija; Laura E Downie
Journal:  BMJ Open       Date:  2018-03-25       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.